Home › Atrial Fibrillation › Tennessee
Atrial Fibrillation clinical trials in Tennessee
13 studies for Atrial Fibrillation are looking for participants at sites in Tennessee.
Cities in Tennessee
ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3
- The Jackson Clinic, PA, Jackson
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT06716021Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- Tennessee Center for Clinical Trials, Tullahoma
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT07430956Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
- East Coast Institute for Research, Jefferson City, Jefferson City
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07175428Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Tennessee Center for Clinical Trials, Tullahoma
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07626411Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
- Vanderbilt University Medical Center, Nashville
Recruiting
Ages 18 and older · All sexes · Updated Oct 19, 2026 · NCT07298473BoxX-NoAF Clinical Trial
- Centennial Medical Center, Nashville
- Ascension Saint Thomas, Nashville
RecruitingHealthy volunteers welcome
Ages 65 and older · All sexes · Updated Oct 7, 2026 · NCT06989775Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
- Jackson-Madison County General Hospital, Jackson
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT04088071The Fourth Left Atrial Appendage Occlusion Study
- The University of Tennessee, Memphis
Recruiting
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT05963698Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation
- Erlanger Medical Center, Chattanooga
Recruiting
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT05723926Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Anthos Investigational site 9954, Chattanooga
- Anthos Investigative Site 9941, Jefferson City
- Anthos Investigative Site 1056, Memphis
RecruitingPhase 3
Ages 65 and older · All sexes · Updated Jul 13, 2026 · NCT05712200Tracking Results of Ablations to Combat AF Registry Generation 2
- Jackson Madison County General Hospital, Jackson
- Centennial Medical Center, Nashville
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05111015Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
- Fort Sanders Regional Medical Center, Knoxville
- Methodist University Hospital, Memphis
- Semmes Murphey Main Campus, Memphis
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 8, 2026 · NCT03907046Defining the Risk of Ventricular Tachycardia in Genetic Cardiomyopathies
- Vanderbilt University Medical Center, Nashville
RecruitingObservational study
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT06575881From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.